Skip to content

Dogwood Therapeutics, Inc.

DWTX

CIK 0001818844 · Pharmaceutical Preparations · Nasdaq

  • Virios Therapeutics, Inc. (until 2024-10-15)
  • Virios Therapeutics, LLC (until 2020-12-16)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$35.46M
−177.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$18.79
+43.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$13.23M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
33.63M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings